Atypical Antipsychotics: Mechanism of Action

Background: Al though the prin ci pal brain tar get that all an tipsy chotic drugs at tach to is the do pamine D2 re cep tor, tra di tional or typi cal an tipsy chot ics, by at tach ing to it, in duce ex tra py r a mi dal signs and symp toms (EPS). They also, by bind ing to the D2 re cep tor, ele vate se rum pro lac tin. Atypi cal a ntipsy chot ics given in dos ages within the clini cally ef fec tive range do not bring about these adverse clini cal ef fects. To un der stand how these drugs work, it is im por tant to ex am ine the atypical an tipsychot ics' mecha nism of ac tion and how it dif fers from that of the more typi cal drugs. Method: This re view analy zes the af fini ties, the oc cu pan cies, and the dis so cia tion time- course of vari ous an tipsy chot ics at do pa mine D2 re cep tors and at se ro tonin (5-HT) re cep tors, both in the test tube and in live pa tients. Results: Of the 31 an tipsy chot ics ex am ined, the older tra di tional an tipsy chot ics such as tri fluperazine, pi mozide, chlor pro maz ine, fluphe nazine, ha loperi dol, and flupen thixol bind more tightly than dopamine it self to the do pa mine D2 re cep tor, with dis so cia tion con stants that are lower than that for do pa mine. The newer, atypi cal an tipsy chot ics such as queti apine, re moxi pride, clo zapine, ol a nzap ine, sert in dole, zi pra si done, and amisul pride all bind more loosely than do pa mine to the do pamine D 2 re cep tor and have dis so cia tion con stants higher than that for do pa mine. These tight and loose bind ing data agree with the rates of an tipsy chotic dis so cia tion from the human- cloned D2 recep tor. For in stance, ra dio ac tive ha loperi dol, chlor pro maz ine, and ra clo pride all dis s o ci ate very slowly over a 30- minute time span, while ra dio ac tive queti apine, clo zap ine, re moxi pride, and amisul pride dis so ci ate rap idly, in less than 60 sec onds. These data also match clini cal brain-imaging find ings that show ha loperi dol re main ing con stantly bound to D2 in hu mans un der go ing 2 posi tron emis sion to mo gra phy (PET) scans 24 hours apart. Con versely, the oc cu pa tion of D2 by clo zap ine or queti apine has mostly dis ap peared af ter 24 hours. Conclusion: Atypi cals clini cally help pa tients by tran siently oc cu py ing D2 re cep tors and then rap idly dis so ci at ing to al low nor mal do pa mine neu ro trans mis sion. This keeps pro lac tin lev els nor mal, spares cog ni tion, and ob vi ates EPS. One the ory of atypi cal ity is that the newer drugs block 5-HT2A re ceptors at the same time as they block do pa mine re cep tors and that, some how, this serotonin- dopam i n e bal ance con fers atypi cal ity. This, how ever, is not borne out by the re sults. While 5-HT2A re cep tors are read ily blocked at low dos ages of most atypi cal an tipsy chotic drugs (with the im por tant ex ceptions of re moxi pride and amisul pride, nei ther of which is avail able for use in Can ada) the do s ages at which this hap pens are be low those needed to al le vi ate psy cho sis. In fact, the an tipsy chotic thresh old oc cu pancy of D 2 for an tipsy chotic ac tion re mains at about 65% for both typi cal and atypi cal an tipsychotic drugs, re gard less of whether 5-HT2A re cep tors are blocked or not. At the same time, the a ntipsy chotic thresh old oc cu pancy of D2 for elic it ing EPS re mains at about 80% for both typi cal and atypi cal an tipsy chot ics, re gard less of the oc cu pancy of 5-HT2A re cep tors. Relevance: The “fast- off-D 2” the ory, on the other hand, pre dicts which an tipsy chotic com pounds will or will not pro duce EPS and hy per pro lac ti ne mia and which com pounds pres ent a rela tiv ely low risk for tar dive dyski ne sia. This the ory also ex plains why L- dopa psy cho sis re sponds t o low atypi cal an tipsy chotic dos ages, and it sug gests vari ous in di vidu al ized treat ment strategies.

[1]  S. Kapur,et al.  Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. , 2000, Journal of psychiatry & neuroscience : JPN.

[2]  Christer Halldin,et al.  Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients , 1993, Biological Psychiatry.

[3]  P. Seeman,et al.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Seeman,et al.  Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.

[5]  G McKay,et al.  PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. , 1997, The American journal of psychiatry.

[6]  P. Seeman,et al.  Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. , 1999, The American journal of psychiatry.

[7]  S. Kasper,et al.  Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol – a 123I-IBZM SPECT study , 1998, Psychopharmacology.

[8]  P. Goldman-Rakic,et al.  The cerebral cortex: a case for a common site of action of antipsychotics. , 1998, Trends in pharmacological sciences.

[9]  L. Farde,et al.  PET Analysis Indicates Atypical Central Dopamine Receptor Occupancy in Clozapine-Treated Patients , 1992, British Journal of Psychiatry.

[10]  P. Seeman,et al.  Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors , 1997, Neuropsychopharmacology.

[11]  A. Malhotra,et al.  D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patients. , 1997, Archives of general psychiatry.

[12]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[13]  C. Halldin,et al.  Positron Emission Tomography of in-vivo Binding Characteristics of Atypical Antipsychotic Drugs , 1996, British Journal of Psychiatry.

[14]  D. Pickar Prospects for pharmacotherapy of schizophrenia , 1995, The Lancet.

[15]  G. Sedvall,et al.  Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.

[16]  Alan A. Wilson,et al.  The D2 Receptor Occupancy Profile of Loxapine Determined Using PET , 1996, Neuropsychopharmacology.

[17]  H. Meltzer,et al.  Effects of antipsychotic drugs on serotonin receptors. , 1991, Pharmacological reviews.

[18]  G. Vankar,et al.  Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia , 2001, Schizophrenia Research.

[19]  P. Seeman,et al.  Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism. , 1996, Japanese journal of pharmacology.

[20]  M. Albus,et al.  D2‐dopamine receptor occupancy differs between patients with and without extrapyramidal side effects , 1994, Acta psychiatrica Scandinavica.

[21]  P. Seeman Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes. , 1988, Journal of clinical psychopharmacology.

[22]  S. Kasper,et al.  IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol , 1997, Psychopharmacology.

[23]  C. Halldin,et al.  Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man , 1995, International clinical psychopharmacology.

[24]  M A Geyer,et al.  5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. , 2001, The Journal of pharmacology and experimental therapeutics.

[25]  P. Seeman Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[26]  S. Kapur,et al.  A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. , 2000, Archives of general psychiatry.

[27]  G. Sedvall,et al.  D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics , 2004, Psychopharmacology.

[28]  A. Labelle,et al.  Phase-IV Multicentre Clinical Study of Risperidone in the Treatment of Outpatients with Schizophrenia , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[29]  H. Meltzer,et al.  Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.

[30]  J. Martinot,et al.  Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients. , 1998, The American journal of psychiatry.

[31]  S. Kasper,et al.  63-2 Sertindole and dopamine D2 receptor occupancy , 1997, Biological Psychiatry.

[32]  Alan A. Wilson,et al.  The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. , 1995, Life sciences.

[33]  S H Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.

[34]  U. Ungerstedt,et al.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. , 1970, European journal of pharmacology.

[35]  L. Cervo,et al.  8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis , 1988, Neuropharmacology.

[36]  J. Browning,et al.  Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats , 2001, Pharmacology Biochemistry and Behavior.

[37]  P. Seeman,et al.  Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors , 1998, Molecular Psychiatry.

[38]  N. Andén,et al.  Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum☆ , 1964 .

[39]  L. Steardo,et al.  New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine , 1995, Neuropsychopharmacology.

[40]  Alan A. Wilson,et al.  5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. , 1998, The American journal of psychiatry.

[41]  S. Kapur,et al.  Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. , 2001, The American journal of psychiatry.